BrainsWay Expands Intellectual Property on TMS Device
BrainsWay’s TMS device is not easy to duplicate in regards to the number of coils and OCD addition to the device. As a result, a patent...
top of page
News & Events
Mar 5, 2019
BrainsWay Announces OCD Clinical Support Program
Ever since the FDA granted BrainsWay to be the only company in the TMS industry to treat OCD, there has been an influx in physicians who...
Mar 4, 2019
BrainsWay Expands Intellectual Property Position by Obtaining Rights to Multi-Channel Transcranial M
BrainsWay Expands Intellectual Property Position by Obtaining Rights to Multi-Channel Transcranial Magnetic Stimulation Patent Portfolio...
Feb 20, 2019
BrainsWay Expands its Deep TMS Commercial Footprint into Asia Pacific
Enters into an Agreement to Distribute its Deep Transcranial Magnetic Stimulation System in South Korea. JERUSALEM, February 20, 2019 –...
Feb 19, 2019
BrainsWay Receives FDA 510(k) Clearance for Use of its Next-Generation Stimulator for the Treatment
BrainsWay Receives FDA 510(k) Clearance for Use of its Next-Generation Stimulator for the Treatment of Obsessive Compulsive Disorder...
Feb 11, 2019
BrainsWay OCD Revolutionizing Treatment of OCD Patients
With the FDA recently clearing BrainsWay Deep TMS treatment for OCD, the mental health community is excited, generating significant...
Jan 29, 2019
BrainsWay Receives PMDA Approval in Japan of Deep Transcranial Magnetic Stimulation System for Treat
BrainsWay Receives PMDA Approval in Japan of Deep Transcranial Magnetic Stimulation System for Treatment of Major Depressive Disorder...
Jan 28, 2019
“After the Smoke Clears” Community Charity Event in Southern California
Calabasas Behavioral Health hosts “After the Smoke Clears”, a free community event offering emotional and mental health to victims of the...
Dec 18, 2018
TMS Treatment for OCD Expands to Alaska
With three Achieve TMS locations in Alaska: Anchorage, Fairbanks, and Wasilla, patients now have the opportunity to receive treatment in...
Dec 12, 2018
BrainsWay Among 8 Medical Products Selected by FDA to Combat the Opioid Crisis
The FDA is trying new strategies to fight the opioid crisis, and devices such as BrainsWay Deep TMS are one way to treat this ongoing...
Dec 11, 2018
BrainsWay Running Clinical Trials to Treat Nicotine Addiction
An interview between renowned neurologist and psychiatrist, Dr. Nolan Williams, and a representative of Medgadget, highlights how...
Dec 10, 2018
BrainsWay Selected to Participate in FDA Innovation Challenge: Devices to Prevent and Treat Opioid U
BrainsWay Selected to Participate in FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder Company’s Deep...
Nov 13, 2018
BrainsWay Ltd. Q3 2018 results – conference call November 13, 2018
Press the link to hear the conference call
Nov 13, 2018
BrainsWay to Showcase FDA-Cleared Deep Transcranial Magnetic Stimulation System for the Treatment of
BrainsWay to Showcase FDA-Cleared Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-Compulsive Disorder at...
Oct 30, 2018
BrainsWay Deep TMS Helping Veterans Suffering From Depression
Often times when a veterans returns home from war, post traumatic stress disorder (PTSD) is a very common result, which eventually leads...
Oct 17, 2018
BrainsWay to Showcase Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-C
BrainsWay to Showcase Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-Compulsive Disorder at the 2018 Annual...
Oct 12, 2018
Mass Live Shows That Medication Has Its Limits
BrainsWay’s Deep TMS device is effective at not only treating depression, but particularly those patients who have not responded to their...
Oct 10, 2018
BrainsWay Announces First Shipments of Deep Transcranial Magnetic Stimulation Helmets for the Treatm
BrainsWay Announces First Shipments of Deep Transcranial Magnetic Stimulation Helmets for the Treatment of Obsessive-Compulsive Disorder...
bottom of page